St Olavs Hospital

Running trials

• Not yet recruiting

  Reconsidering Long-Term Apirin in the Elderly in Secondary Prevention of Coronary Artery Disease Norway

  NCT07854795· Phase 4· Source

• Recruiting

  Proton Re-irradiation in Patients With Recurrent or Second Primary Head and Neck Cancer , a Multicentre Phase II Single Arm Trial

  NCT07922967· Source

• Not yet recruiting

  Deep Learning-Based Automated Pressure-Strain Loop Analysis

  NCT07850726· Source

• Not yet recruiting

  Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.

  NCT07757412· Phase 2· Source

• Recruiting

  Proton Versus Photon Therapy in Head and Neck Squamous Cell Carcinomas.

  NCT07580300· Phase 3· Source

• Recruiting

  Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer

  NCT07422597· Source

• Enrolling by invitation

  Collaboratory Treatment Pathway for Chronic Pain Patients.

  NCT07331766· Source

• Recruiting

  Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

  NCT06419946· Phase 3· Source

• Recruiting

  Effect of Patient Education on Drinking Behaviour and Oral Hygiene in Patients Undergoing Bariatric Surgery

  NCT06617689· Source

• Active, not recruiting

  A Study Investigating Peripheral Cryoneurolysis in Adults With Chronic Migraine

  NCT06554886· Source

• Active, not recruiting

  Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)

  NCT06440629· Phase 4· Source

• Recruiting

  RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3

  NCT06297902· Source

• Recruiting

  Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

  NCT06362707· Phase 2· Source

• Recruiting

  Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients

  NCT06505369· Phase 2· Source

• Enrolling by invitation

  Biological Changes Associated With High Risk of Preeclampsia in Nulliparous Women

  NCT06200571· Source

• Recruiting

  Prophylactic Treatment With Atorvastatin for Episodic Migraine.

  NCT06248671· Phase 2· Source

• Recruiting

  Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)

  NCT06485336· Phase 2· Source

• Recruiting

  The Lumbar Interbody Fusion vs. Multidisciplinary Rehabilitation (LIFEHAB) Trial

  NCT06169488· Source

• Active, not recruiting

  Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks

  NCT06108947· Source

• Active, not recruiting

  A Digital Therapeutic to Improve Insomnia in Multiple Sclerosis: A Randomized Controlled Trial.

  NCT06113666· Source

• Active, not recruiting

  Intraarticular Steroids, Saline and Occupational Therapy in People With CMC1 Osteoarthritis

  NCT06084364· Phase 4· Source

• Recruiting

  Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries

  NCT05849857· Phase 2· Source

• Recruiting

  Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families

  NCT05744310· Source

• Recruiting

  Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

  NCT05448547· Phase 3· Source

• Recruiting

  Embolization for Meningioma

  NCT05416567· Source

• Recruiting

  Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer

  NCT05377047· Phase 3· Source

• Recruiting

  Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

  NCT04628026· Phase 3· Source

• Recruiting

  A Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment

  NCT04917601· Source

• Active, not recruiting

  Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries

  NCT05143138· Source

• Recruiting

  Enabling Parents of Children With Autism Spectrum Disorders - a Randomized Controlled Trial of Parenting Programs

  NCT05750095· Source

• Active, not recruiting

  A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

  NCT04965493· Phase 3· Source

• Recruiting

  A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  NCT04844606· Phase 3· Source

• Recruiting

  Improving Public Cancer Care by Implementing Precision Medicine in Norway

  NCT04817956· Phase 2· Source

• Recruiting

  Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer

  NCT04460352· Phase 3· Source

• Active, not recruiting

  Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae

  NCT04541056· Source

• Active, not recruiting

  Supramarginal Resection in Glioblastoma

  NCT04243005· Source

• Active, not recruiting

  Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study

  NCT04392505· Phase 2· Source

• Recruiting

  Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing

  NCT03889743· Phase 4· Source

• Recruiting

  A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)

  NCT04771507· Phase 1/2· Source

• Active, not recruiting

  Persona Cohort Nordic Multicenter Study

  NCT03495232· Source

• Active, not recruiting

  The p53 Breast Cancer Trial

  NCT02965950· Phase 2· Source

• Active, not recruiting

  MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway

  NCT03962127· Source

• Recruiting

  Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer

  NCT02102477· Source

• Active, not recruiting

  Curative Image Guided Radiotherapy for Prostate Cancer

  NCT01550237· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Head and neck cancer3 recruiting
• Prostate cancer3 recruiting
• Migraine2 recruiting
• Multiple myeloma2 recruiting
• Acute myeloid leukaemia1 recruiting
• ALS (motor neurone disease)1 recruiting
• Alzheimer disease1 recruiting
• Asthma1 recruiting
• Autism1 recruiting
• Childhood cancers1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Follicular lymphoma1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Glioblastoma1 recruiting
• Heart failure1 recruiting
• Meningioma1 recruiting
• Metastatic breast cancer1 recruiting
• Myelodysplastic syndromes1 recruiting
• Obesity1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Happy Hands - an E-self-management Intervention for People With Hand Osteoarthritis

  NCT05568875· Source

• Completed

  The Norwegian Exercise in Atrial Fibrillation Trial

  NCT05164718· Source

• Completed

  Virtual Surgery of the Upper Airways

  NCT04829201· Source

• Completed

  Candesartan for Migraine Prevention:

  NCT04574713· Phase 2· Source

• Completed

  Digital Cognitive Behavior Therapy for Insomnia Compared With Digital Patient Education About Insomnia in Individuals Referred to Public Mental Health Services in Norway

  NCT04621643· Source

• Completed

  The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study

  NCT04122235· Source

• Terminated

  "Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.

  NCT03402477· Source

• Completed

  Aspirin in Colorectal Cancer Liver Metastases

  NCT03326791· Phase 2/3· Source

• Completed

  Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

  NCT03260894· Phase 3· Source

• Completed

  BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma

  NCT02872259· Phase 1/2· Source

• Recruiting

  The Norwegian Antirheumatic Drug Register

  NCT01581294· Source